GCTK · Forms 3, 4, 5
Insider trades at Glucotrack, Inc.
No open-market insider buys or sells at Glucotrack, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Glucotrack, Inc. (GCTK) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Glucotrack, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Brendel Victoria Carr | Director | Became an insider (Form 3) | Form 3 | ||||
| Andrew K Balo | Director | Award | 1,285 | Form 4 | |||
| Luis Malave | Director | Award | 463 | Form 4 | |||
| Erin Catherine Carter | Director | Award | 386 | Form 4 | |||
| Andrew K Balo | Director | Award | 3,332 | Form 4 | |||
| Luis Malave | Director | Award | 1,200 | Form 4 | |||
| Erin Catherine Carter | Director | Award | 1,000 | Form 4 | |||
| John Ballantyne | Director | Award | 4,126 | Form 4 | |||
| Luis Malave | Director | Award | 2,076 | Form 4 | |||
| Erin Catherine Carter | Director | Award | 1,896 | Form 4 | |||
| Andrew K Balo | Director | Award | 75 | Form 4 | |||
| Luis Malave | Director | Award | 35 | Form 4 | |||
| Erin Catherine Carter | Director | Award | 32 | Form 4 | |||
| Paul Goode | Chief Executive Officer | Other | 42 | Form 4 | |||
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 | 10% owner | Option exercise | 2,560,553 | Form 4 | |||
| John Ballantyne | Director | Option exercise | 2,560,553 | Form 4 | |||
| Luis Malave | Director | Option exercise | 133,532 | Form 4 | |||
| Erin Catherine Carter | Director | Option exercise | 40,297 | Form 4 | |||
| Paul Goode | Chief Executive Officer | Option exercise | 15,435 | Form 4 | |||
| Paul Goode | Chief Executive Officer | Other | 1,500 | Form 4 | |||
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 | 10% owner | Other | 132,036 | $31.00 | $4.1M | Form 4 | |
| John Ballantyne | Director | Other | 132,036 | $31.00 | $4.1M | Form 4 | |
| Luis Malave | Director | Conversion | 6,886 | $31.20 | $215K | Form 4 | |
| Erin Catherine Carter | Director | Conversion | 2,078 | $31.20 | $65K | Form 4 | |
| Paul Goode | Chief Executive Officer | Conversion | 796 | $31.20 | $25K | Form 4 | |
| Luis Malave | Director | Award | 489 | Form 4 | |||
| Erin Catherine Carter | Director | Award | 458 | Form 4 | |||
| Luis Malave | Director | Award | 362 | Form 4 | |||
| Erin Catherine Carter | Director | Award | 903 | Form 4 | |||
| Luis Malave | Director | Award | 121 | Form 4 | |||
| Luis Malave | Director | Award | 29 | Form 4 | |||
| Luis Malave | Director | Award | 44 | Form 4 | |||
| Luis Malave | Director | Award | 34 | Form 4 | |||
| Luis Malave | Director | Award | 25 | Form 4 | |||
| Luis Malave | Director | Award | 11 | Form 4 | |||
| Luis Malave | Director | Award | 8 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.